These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1141 related items for PubMed ID: 16490581

  • 41. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
    Tripp K, McVicar WK, Nair P, Corren J, Pleskow WW, Goodwin E, Baumgartner RA, Hanrahan JP.
    J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
    [Abstract] [Full Text] [Related]

  • 42. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
    Katial RK, Bernstein D, Prazma CM, Lincourt WR, Stempel DA.
    Allergy Asthma Proc; 2011 Sep; 32(2):127-36. PubMed ID: 21189151
    [Abstract] [Full Text] [Related]

  • 43. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [Abstract] [Full Text] [Related]

  • 44. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
    Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS.
    Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625
    [Abstract] [Full Text] [Related]

  • 45. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
    Bergmann KC, Lindemann L, Braun R, Steinkamp G.
    Swiss Med Wkly; 2004 Jan 24; 134(3-4):50-8. PubMed ID: 14745658
    [Abstract] [Full Text] [Related]

  • 46. Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone.
    Bailey W, Castro M, Matz J, White M, Dransfield M, Yancey S, Ortega H.
    Curr Med Res Opin; 2008 Jun 24; 24(6):1669-82. PubMed ID: 18462564
    [Abstract] [Full Text] [Related]

  • 47. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma.
    Sher LD, Yiu G, Sakov A, Liu S, Caracta CF.
    Allergy Asthma Proc; 2017 Sep 21; 38(5):343-353. PubMed ID: 28639542
    [Abstract] [Full Text] [Related]

  • 48. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
    Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jun 21; 96(6):808-18. PubMed ID: 16802768
    [Abstract] [Full Text] [Related]

  • 49. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R, Adelglass J, Clifford DP, Duke SP, Wire PD, Faris M, Harding SM.
    Chest; 2000 Aug 21; 118(2):303-12. PubMed ID: 10936117
    [Abstract] [Full Text] [Related]

  • 50. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
    Lumry W, Noveck R, Weinstein S, Barnhart F, Vandermeer A, Murray A, Reisner C.
    Ann Allergy Asthma Immunol; 2001 Mar 21; 86(3):297-303. PubMed ID: 11289328
    [Abstract] [Full Text] [Related]

  • 51. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun 21; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 52. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
    Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.
    Treat Respir Med; 2004 Jun 21; 3(3):173-81. PubMed ID: 15219176
    [Abstract] [Full Text] [Related]

  • 53. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May 21; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

  • 54. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
    Bernstein D, Andersen L, Forth R, Jacques L, Yates L.
    J Asthma; 2018 Sep 21; 55(9):984-993. PubMed ID: 28961020
    [Abstract] [Full Text] [Related]

  • 55. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul 21; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 56. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
    Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K.
    Ann Allergy Asthma Immunol; 1999 Apr 21; 82(4):383-9. PubMed ID: 10227337
    [Abstract] [Full Text] [Related]

  • 57. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS, Custovic A, Lowe LA, Aldington S, Williams M, Beasley R, Woodcock A.
    Allergy Asthma Proc; 2010 Apr 21; 31(5):415-21. PubMed ID: 20929609
    [Abstract] [Full Text] [Related]

  • 58. Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness.
    Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A.
    Chest; 2002 Sep 21; 122(3):806-11. PubMed ID: 12226017
    [Abstract] [Full Text] [Related]

  • 59. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
    Welch M, Bernstein D, Gross G, Kane RE, Banerji D.
    Chest; 1999 Nov 21; 116(5):1304-12. PubMed ID: 10559092
    [Abstract] [Full Text] [Related]

  • 60. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar 21; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.